Literature DB >> 11246841

Tubal sterilization and risk of breast cancer mortality in US women.

E E Calle1, C Rodriguez, K A Walker, P A Wingo, J M Petrelli, M J Thun.   

Abstract

OBJECTIVE: To investigate the hypothesis that tubal sterilization is associated with a reduced risk of breast cancer.
METHODS: We examined this hypothesis in a large prospective study of US adults. After 14 years of mortality follow-up, 3837 deaths from breast cancer were observed in a cohort of 619,199 women who were cancer-free at study entry in 1982.
RESULTS: Cox proportional hazards models (adjusted for multiple breast cancer risk factors) showed a significant inverse association between tubal sterilization and breast cancer mortality (adjusted rate ratio (RR) = 0.82, 95% confidence interval (CI) 0.70-0.96). Women who were sterilized before age 35 had a lower risk (adjusted RR = 0.69, 95% CI 0.53-0.88) than women who were sterilized at 35 years of age or older (adjusted RR = 0.92, 95% CI 0.75-1.13). Also, sterilizations performed before 1975 resulted in a lower risk (RR = 0.75, 95% CI 0.62-0.91) than those performed during or after 1975 (RR = 0.98, 95% CI 0.74-1.29), possibly reflecting the likelihood of greater tissue damage with earlier procedures.
CONCLUSIONS: These results suggest that tubal sterilization may lower subsequent risk of breast cancer, especially among women who are sterilized at a relatively young age. Additional studies are needed to confirm or refute these findings.

Entities:  

Mesh:

Year:  2001        PMID: 11246841     DOI: 10.1023/a:1008914209146

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  5 in total

1.  The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women.

Authors:  Kim N Danforth; A Heather Eliassen; Shelley S Tworoger; Stacey A Missmer; Robert L Barbieri; Bernard A Rosner; Graham A Colditz; Susan E Hankinson
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

2.  Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study.

Authors:  David J Press; Jane Sullivan-Halley; Giske Ursin; Dennis Deapen; Jill A McDonald; Brian L Strom; Sandra A Norman; Michael S Simon; Polly A Marchbanks; Suzanne G Folger; Jonathan M Liff; Ronald T Burkman; Kathleen E Malone; Linda K Weiss; Robert Spirtas; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2010-11-25       Impact factor: 4.897

3.  A systematic review and meta-analysis on tubal ligation and breast cancer risk.

Authors:  Nazila Najdi; Arezoo Esmailzadeh; Maryam Shokrpour; Somayeh Nikfar; Seyedeh Zahra Razavi; Mahdi Sepidarkish; Saman Maroufizadeh; Saeid Safiri; Amir Almasi-Hashiani
Journal:  Syst Rev       Date:  2022-06-19

4.  Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study.

Authors:  Kezia Gaitskell; Kate Coffey; Jane Green; Kirstin Pirie; Gillian K Reeves; Ahmed A Ahmed; Isobel Barnes; Valerie Beral
Journal:  Br J Cancer       Date:  2016-04-21       Impact factor: 7.640

5.  Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trial.

Authors:  Xin Huang; Chuanbo Xie; Jie Tang; Wenzhuo He; Fan Yang; Wenfang Tian; Jundong Li; Qiuxia Yang; Jingxian Shen; Liangping Xia; Chunyan Lan
Journal:  BMC Med       Date:  2020-10-05       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.